Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-27 4:14 pm Purchase | 2024-02-26 | 13G | Liberty Live Group LLYVA | Point72 Asset Management, L.P. | 1,287,149 5.000% | 1,287,149![]() (New Position) | Filing History |
| 2024-02-23 4:28 pm Purchase | 2024-02-22 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 3,017,093 5.100% | 3,017,093![]() (New Position) | Filing History |
| 2024-02-23 4:15 pm Purchase | 2024-02-22 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 4,432,602 5.000% | 435,057![]() (+10.88%) | Filing History |
| 2024-02-21 4:16 pm Purchase | 2024-02-20 | 13G | Agenus Inc. AGEN | Point72 Asset Management, L.P. | 1,413,425 6.800% | 1,413,368![]() (+2492389.95%) | Filing History |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 1,649,740 6.400% | 499,092![]() (+43.37%) | Filing History |
| 2024-02-14 4:19 pm Purchase | 2023-12-31 | 13G | PagSeguro Digital Ltd. PAGS | Point72 Asset Management, L.P. | 10,933,610 5.600% | 231,012![]() (+2.16%) | Filing History |
| 2024-02-14 4:18 pm Purchase | 2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Point72 Asset Management, L.P. | 60,606 5.800% | 606![]() (+1.01%) | Filing History |
| 2024-02-14 4:17 pm Sale | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Point72 Asset Management, L.P. | 2,756,122 5.000% | -866,014![]() (-23.91%) | Filing History |
| 2024-02-14 4:17 pm Sale | 2023-12-31 | 13G | Madison Square Garden Entertainment Corp. MSGE | Point72 Asset Management, L.P. | 2,299,168 5.600% | -4,445![]() (-0.19%) | Filing History |
| 2024-02-14 4:16 pm Purchase | 2023-12-31 | 13G | TPI Composites, Inc. TPICQ | Point72 Asset Management, L.P. | 3,286,322 7.100% | 1,154,151![]() (+54.13%) | Filing History |
| 2024-02-14 4:15 pm Purchase | 2023-12-31 | 13G | Morphic Holding, Inc. MORF | Point72 Asset Management, L.P. | 4,591,000 9.200% | 2,086,617![]() (+83.32%) | Filing History |
| 2024-02-14 4:14 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 3,416,900 5.100% | -311,052![]() (-8.34%) | Filing History |
| 2024-02-14 4:14 pm Purchase | 2023-12-31 | 13G | Cybin Inc. Common Stock HELP | Point72 Asset Management, L.P. | 30,061,112 7.400% | 30,061,112![]() (New Position) | Filing History |
| 2024-02-14 4:13 pm Purchase | 2023-12-31 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 4,159,454 7.200% | 1,334,524![]() (+47.24%) | Filing History |
| 2024-02-14 4:12 pm Purchase | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 758,185 8.600% | 758,185![]() (New Position) | Filing History |
| 2024-02-14 4:11 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 5,243,623 6.100% | 1,680,721![]() (+47.17%) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Point72 Asset Management, L.P. | 4,040,000 9.400% | 1,918,830![]() (+90.46%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management, L.P. | 493,400 0.900% | -3,021,956![]() (-85.96%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 3,974,873 4.200% | -3,727,958![]() (-48.40%) | Filing History |
| 2024-02-14 10:04 am Sale | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 65,754 1.700% | -185,512![]() (-73.83%) | Filing History |

